E. Portaccio; B. Goretti; C. Niccolai; B. Hakiki; M. iannini; L. Pastò; C. Pecori; L. Razzolini; M. Falautano; E. Minacapelli; V. Martinelli; C. Incerti; U. Nocentini; M. Murgia; G. Fenu; E. Cocco; MG Marrosu; E. Garofalo; FI Ambra; M. Maddestra; M. Consalvo; RG Viterbo; M. Trojano; NA Losignore; GB Zimatore; E. Pietrolongo; A. Lugaresi; L. Pippolo; M. Roscio; A. Ghezzi; D. Castellano; S. Stecchi; MP Amato., A comparison of the Brief International Cognitive Assessment for Multiple Sclerosis and a brief repeatable battery in multiple sclerosis patients., «MULTIPLE SCLEROSIS», 2014, 20, pp. 124 - 125 [abstract]
E. Portaccio; B. Goretti; C. Niccolai; B. Hakiki; M. Giannini; L. Pastò; C. Pecori; F. Razzolini; M. Falautano; E. Minacapelli; V. Martinelli; C. Incerti; U. Nocentini; M.
Murgia; G. Fenu; E. Cocco; M. Marrosu; E. Garofalo; F. Ambra; M. Maddestra; M.
Consalvo; R. Viterbo; M. Trojano; N. Losignore; G. Zimatore; E. Pietrolongo; A. Lugaresi; L. Pippolo; M. Roscio; A. Ghezzi; D. Castellano; S. Stecchi; M. Amato, A comparison of the brief International cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients., «NEUROLOGICAL SCIENCES», 2014, 35, pp. 65 - 65 [abstract]
V. Di Tommaso; L. Mancinelli; M. Matteo; D. Travaglini; D. Farina; M. di Ioia; G. De Luca; E. Pietrolongo; A. Lugaresi, Anti-JCV serostatus, index value and clinical features in patients affected by multiple sclerosis., «NEUROLOGICAL SCIENCES», 2014, 35, pp. 355 - 356 [abstract]
T. Kalincik; D. Horakova; T. Spelman; V. Jokubaitis; M. Trojano; A. Lugaresi; G. Izquierdo; C. Rozsa; P.Grammond; R. Alroughani; P. Duquette; M. Girard; E. Pucci; J. Lechner-Scott; M. Slee; R. Fernandez-Bolanos; F. Grand’Maison; R. Hupperts; F. Verheul; S. Hodgkinson; C. Oreja-Guevara; D. Spitalieri; M. Barnett; M. Terzi; R. Bergamaschi; P. McCombe; J. Sanchez- Menoyo; M. Simo; T. Csepany; G. Rum; C. Boz; E. Havrdova; H. Butzkueven; Ms Base Study Group., Comparative efficacy of switch to natalizumab of fingolimod in active relapsing.remitting multiple sclerosis, «MULTIPLE SCLEROSIS», 2014, 20, pp. 195 - 196 [abstract]
A. He; T. Spelman; V Jokubaitis; A. Lugaresi; G. Izquiero; M. Trojano; P. Grammond; J. Lechner-Scott; P. Duquette; M. Girard; E. Pucci; M. Slee; F. Grand’Maison; C . Oreja-Guevara; C. Boz; R. Fernandez-Bolanos; S. Hodgkinson; J. Sanchez-Menoyo; G. Iuliano; M. Barnett; F. Moore; H. Butzkueven; T. Kalincik; Ms Base Study Group., Comparison of fingolimod versus interferon-beta/glatiramer acetate as second-line therapy in active multiple sclerosis, «MULTIPLE SCLEROSIS», 2014, 20, pp. 193 - 193 [abstract]
M. di Ioia; D. Pieragostino; C. Rossi; M. Zucchelli; M. D’Alessandro; A. Lugaresi; D. Travaglini; D. Farina; P. Sacchetta; P. Del Boccio, Development of methods for lipid extraction from CSF and application of mass spectometry techniques for the characterization of the lipid profile and neurosteroids levels in MS patients, «NEUROLOGICAL SCIENCES», 2014, 35, pp. 335 - 335 [abstract]
A. Bertolotto; F. Marnetto; M. Caldano; A. Lugaresi; M. Spadaro, Effect of Natalizumb treatment on circulating CD4+CD62L+T-cells in multiple sclerosis patients., «NEUROLOGICAL SCIENCES», 2014, 35, pp. 277 - 277 [abstract]
Bertolotto, A.; Capobianco, M.; Amato, M. P.; Capello, E.; Capra, R.; Centonze, D.; Di Ioia, M.; Gallo, A.; Grimaldi, L.; Imberti, L.; Lugaresi, A.; Mancinelli, C.; Marrosu, M. G.; Moiola, L.; Montanari, E.; Romano, S.; Musu, L.; Paolicelli, D.; Patti, F.; Pozzilli, C.; Rossi, S.; Salvetti, M.; Tedeschi, G.; Tola, M. R.; Trojano, M.; Zaffaroni, M.; Malucchi, S., Erratum: Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: Report from the Italian Multiple Sclerosis Study group (Neurological Sciences (2014)), «NEUROLOGICAL SCIENCES», 2014, 35, pp. 1645 - 1646 [replica/breve intervento]
T. Kalincik; V. Jokubaitis; T. Spelman; D. Horakova; E. Havrdova; M. Trojano; G. Izquierdo; M. Girard; P. Duquette; A. Lugaresi; F. Grand’Maison; P. Grammond; R. Hupperts; C. Oreja-Guevara; E. Pucci; C. Boz; R. Bergamaschi; J. Lechner-Scott; L. Alroughani; V.Van Pesch; G. Iuliano; M. Rio; R. Fernande-Bolanos; C. Ramo; M. Terzi; T. Petersen; M. Slee; D. Spitalieri; MP Amato; F Verheul; E. Cristiano; J. Sanchez-Menoyo; M. Fiol; O. Gray; JA. Cabrera-Gomez; S. Hodgkinson; M. Barnett; M. Saladino; S. Vucic; C. Shaw; F. Moore; E Van Muster; C. Rozsa; P. McCombe; H. Butzkueven, Evaluation of common criteria of progression of disability in a large observational cohort., «MULTIPLE SCLEROSIS», 2014, 20, pp. 62 - 63 [abstract]
Borreani C; Giordano A; Falautano M; Lugaresi A; Martinelli V; Granella F; Tortorella C; Plasmati I; Radaelli M; Farina D; Dalla Bella E; Bianchi E; Acquarone N; Miccinesi G; Solari A; SIMS-Trial group [ ..; Mattarozzi K; ], Experience of an information aid for newly diagnosed multiple sclerosis patients: a qualitative study on the SIMS-Trial., «HEALTH EXPECTATIONS», 2014, 17, pp. 36 - 48 [articolo]
Jokubaitis Vg; Li V; Kalincik T; Izquierdo G; Hodgkinson S; Alroughani R; Lechner-Scott J; Lugaresi A; Duquette P; Girard M; Barnett M; Grand'Maison F; Trojano M; Slee M; Giuliani G; Shaw C; Boz C; Spitaleri Dl; Verheul F; Haartsen J; Liew D; Butzkueven H, Fingolimod after natalizumab and the risk
of short-term relapse, «NEUROLOGY», 2014, 82, pp. 1204 - 1211 [articolo]
Lugaresi A; Rottoli MR; Patti F, Fostering adherence to injectable disease-modifying therapies in multiple sclerosis., «EXPERT REVIEW OF NEUROTHERAPEUTICS», 2014, 14, pp. 1029 - 1042 [articolo]
Bertolotto A; Capobianco M; Amato MP; Capello E; Capra R; Centonze D; Di Ioia M; Gallo A; Grimaldi L; Imberti L; Lugaresi A; Mancinelli C; Marrosu MG; Moiola L; Montanari E; Romano S; Musu L; Paolicelli D; Patti F; Pozzilli C; Rossi S; Salvetti M; Tedeschi G; Tola MR; Troiano M; Zaffaroni M; Malucchi S, Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group., «NEUROLOGICAL SCIENCES», 2014, 35, pp. 307 - 316 [articolo]
Giordano A; Lugaresi A; Confalonieri P; Granella F; Radice D; Trojano M; Martinelli V; Solari A; on behalf of the SIMS-Practice groupa, Implementation of the 'Sapere Migliora' information aid for newly diagnosed people with multiple sclerosis in routine clinical practice: a late-phase controlled trial., «MULTIPLE SCLEROSIS», 2014, 20, pp. 1234 - 1243 [articolo]
T. Spelman; C. Meyniel; M. Trojano; A. Lugaresi; G. Izquierdo; F. Grand’Maison; C. Boz; L. Alroughani; E. Havvrdova; G. Iuliano; P. Duquette; M. Terzi; P. Grammond; JA. Cabrera-Gomez; R. Hupperts; J. Lechner-Scott; H. Butzkueven, Indipendent predictors of time to relapse after CIS in high-risk patients., «MULTIPLE SCLEROSIS», 2014, 20, pp. 54 - 54 [abstract]
